N/A
Completed N=7
Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure
Source: ClinicalTrials.gov NCT05310877 ↗Enrolled (actual)
7
Serious AEs
14.3%
Results posted
Jun 2023
Primary outcomePrimary: Feasibility of Recruitment Procedures — 7 Participants
Summary
Heart failure (HF) represents a significant public health concern. Medication non-adherence represents a modifiable contributor to costly hospital readmissions in older adults with HF. Educational interventions improve, but do not eliminate, non-adherence. Values affirmation interventions which invite individuals to reflect on core values may encourage better engagement in health behaviors by increasing the personal relevance of targeted behaviors. Similar interventions have promoted weight loss, increased adherence and physical activity, and more frequent fruit and vegetable consumption in a variety of contexts and populations. This study seeks to test a recently developed values-affirmation intervention targeting medication adherence in older adults with HF enrolled in cardiac rehabilitation (CR). The purpose of this feasibility study is to test methodology to aid development of a subsequent randomized controlled pilot trial to examine preliminary efficacy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Recruitment Procedures |
7 | — |
| PRIMARY Feasibility of Intervention Procedures |
6 | — |
| PRIMARY Acceptability Assessed Via Qualitative Exit Interview- Number of Participants Who Completed Interview |
7 | — |
| SECONDARY Self-reported Medication Adherence |
96.69; 99.05 | — |
Eligibility Criteria
Inclusion Criteria
- Heart failure
- Enrolled in cardiac rehabilitation
- Read and understand English
- At risk for medication non-adherence based on self-report screening or number of prescribed medications
Exclusion Criteria
- Current participation in another medication-monitoring clinical or research protocol
- New York Heart Association class IV heart failure
- Diagnosis of Alzheimer's, dementia, or severe cognitive impairment indicated on screening
- Current suicidality or psychosis
- Terminal illness with an expected lifespan of less than 6 months
Data sourced from ClinicalTrials.gov (NCT05310877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.